Global Acne Treatment Market is expected to grow at an approximate CAGR of 5.3% during the forecast period. Acne, also known as acne vulgaris is a skin condition characterized by the clogging of hair follicles with oil or dead skin cells. The skin condition can be persistent even after treatments. Acne is estimated to affect the areas of the skin which have a relatively high number of oil glands, i.e., face, the upper part of the chest, and back. Pustules, nodules, cystic lesions, papules, among others are some of the common symptoms of the disease. Acne is common among teenagers. Increasing prevalence of the acne and growing teenage population are the active drivers of the Acne Treatment Market growth during the forecast period. According to the Acne and Rosacea Society of Canada in 2016, acne affected ~90% of the teens in Canada. Moreover, it was estimated that ~5 million people within the region have acne.
Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/834
Additionally, cosmetic expenditures and increasing awareness of the disease boosts the acne treatment market growth. According to the American Society for Aesthetic Plastic Surgery in 2016, the Americans spent more than USD 13.5 billion on aesthetic procedures (surgical and nonsurgical). The estimated increase from 2014 was about USD 1.5 billion. However, factors such as reported cases of acute reactions caused by the non-prescription acne care products and the high cost of therapeutic procedures like microdermabrasion, dermabrasion, and others may restrain the market growth during the forecast period. According to the American Society of Plastic Surgeons in 2016, the average cost of dermabrasion was estimated to be about USD 1,162, excluding the anesthetic and other related expenses.
Segmentation
The global acne treatment market is segmented on the basis of type, treatment, treatment modality, and end users. On the basis of the type, the market is segmented into comedonal acne, inflammatory acne, cystic acne, post-surgical/wound acne, and others. On the basis of treatment, the market is categorized into medication, therapeutic devices, and others. The medication segment is-sub segmented into retinoid, antibiotics, and others. The retinoid segment is further segmented into adapalene, tretinoin, others. The antibiotics segment is further segmented into erythromycin, clindamycin, and others. The therapeutic devices segment is sub-segmented into lasers, microdermabrader, dermabradors, and others. On the basis of treatment modality, the market is segmented into oral, topical, injectable. On the basis of end users, the market is segmented into hospitals & clinics, pharmacies & drug stores, ambulatory surgical centers, and others.
Regional Analysis
America dominates the global acne treatment market owing to a well-developed healthcare sector and a huge patient population within the region. Moreover, changing lifestyle and increasing cosmetic expenditure provides a boost to the market growth in the Americas. Europe holds the second largest market for acne treatment across the globe due to availability of funds for research, a huge patient population and increasing teenage population within the region. Asia Pacific is projected to be the fastest growing region for the market for acne treatment. This can be attributed due to increasing prevalence of acne, and continuously developing economies like India and China within the region. Additionally, a developing healthcare sector within the region fuels the market growth. On the other hand, the Middle East & Africa holds the least share in the global acne treatment market. Presence of poor economies, stringent government policies and lack of healthcare services are the factors restraining the growth of the market within the region. It is estimated that a majority of the acne treatment market within the Middle East and Africa is held by the Middle East due to a well-developed healthcare sector and huge healthcare expenditure by the developed economies like Saudi Arabia, Dubai, Kuwait within the region.
Key Players
The key players for the global acne treatment market are ALLERGAN (Republic of Ireland), Galderma S.A. (Switzerland), Stiefel Laboratories, Inc. (U.S.), Valeant (Canada), Johnson & Johnson Services, Inc. (U.S.), GlaxoSmithKline Plc. (U.K), Teva Pharmaceutical Industries Ltd. (Israel), Bayer AG (Germany), Roche Holding AG (Switzerland), and others.
Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/acne-treatment-market-5675
No comments:
Post a Comment